Sfoglia per AUTORE
FERRERO S
Collezione ASL Biella

  

Items : 14

A Clinicopathologic Comparison Between Early-Onset and Late-Onset Small Bowel Adenocarcinoma: A Multicenter International Study in American Journal of Gastroenterology

2024
ASL Biella

Arpa G; Vanoli A; Antoci F; Lenti MV; Di Sabatino A; Guerini C; Grillo F; Bianchi PI; Aronico N; Libera L; Furlan D; Travaglino E; Nesi G; Sampietro G; Ardizzone S; Fociani P; Fiocca R; Latella G; Sessa F; D’Errico A; Malvi D; Mescoli C; Rugge M; Ferrero S; Poggioli G; Rizzello F; Macciomei MC; Santini D; Volta U; et alii...

HYPOMETHYLATION OF LINE-1 IN SMALL BOWEL CARCINOMAS AND COELIAC DISEASE in Digestive and Liver Disease

2023
ASL Biella

Guerini C; Bianchi PI; Libera L; Vanoli A; Arpa G; Aronico N; Furlan D; Grillo F; Nesi G; Sampietro G; Ardizzone S; Fociani P; Fiocca R; Latella G; Sessa F; D'Errico A; Malvi D; Mescoli C; Rugge M; Ferrero S; Poggioli G; Rizzello F; Macciomei MC; Santini D; Volta U; De Giorgio R; Caio G; Calabro A; Ciacci C; et alii...

SMALL BOWEL CARCINOMAS MAY COMPLICATE COELIAC DISEASE DESPITE STRICT ADHERENCE TO GLUTEN-FREE DIET: A CASE SERIES FROM THE SMALL BOWEL CANCER ITALIAN CONSORTIUM in Digestive and Liver Disease

2023
ASL Biella

Bianchi PI; Vanoli A; Lenti MV; Guerini C; Arpa G; Quaquarini E; Aronico N; Grillo F; Nesi G; Furlan D; Latella G; Sessa F; Mescoli C; Rugge M; Ferrero S; Macciomei MC; Santini D; Volta U; De Giorgio R; Caio G; Calabro A; Ciacci C; D'Armiento M; Villanacci V; Cannizzaro R; Canzonieri V; Florena AM; Ciardi A; Elli L; et alii...

Rituximab and Lenalidomide (R 2) Vs Rituximab Alone As Maintenance Treatment after Chemoimmunotherapy for Elderly Patients with Relapsed/Refractory Follicular Lymphoma (FL): Final Analysis of Renoir Phase III Study of the Fondazione Italiana Linfomi (FIL) in Blood

2023
ASL Biella

Boccomini C; Botto B; Evangelista A; Zilioli VR; Anastasia A; Cavallo F; Merli F; Zanni M; Tani M; Chiarenza A; Liberati AM; Conconi A; Corradini P; Bari A; Annechini G; Gaidano G; Spina M; Sartori R; Castellino C; Puccini B; Arcari A; Bigliardi S; Matta G; Merli M; Mannina D; Marino D; Galieni P; Ciambelli F; Musuraca G; et alii...

Prognostic Role of Mismatch Repair Status, Histotype and High-Risk Pathologic Features in Stage II Small Bowel Adenocarcinomas. in Annals of surgical oncology / Ann Surg Oncol. 2021 Feb;28(2):1167-1177. doi: 10.1245/s10434-020-08926-4. Epub 2020 Aug 5.

2021
ASL Biella

Pietrabissa A; Pedrazzoli P; Luinetti O; Biletta E; Amodeo G; Ciccocioppo R; Barresi V; Orlandi A; Giannone AG; Reggiani Bonetti L; Oreggia B; Lenti MV; D'Odorico A; Zingone F; D'Incà R; Vecchi M; Elli L; Caprioli F; Ciardi A; Monteleone G; Caronna R; Biancone L; Canzonieri V; Florena AM; Villanacci V; Solcia E; Cannizzaro R; Tonelli F; Solina G; et alii...

Treatment of Relapsed/Refractory Waldenström Macroglobulinemia Patients: Final Clinical and Molecular Results of the Phase II Brb (Bendamustine, Rituximab and Bortezomib) Trial of the Fondazione Italiana Linfomi (FIL) in Blood

2021
AOU Città della Salute di Torino
ASL Biella

Benevolo G; Ferrero S; Villivà N; Castiglione A; Monaco F; Boccomini C; Cabras MG; Califano C; Casula P; Cavallo F; Conconi A; Drandi D; Gaidano G; Gregorini AI; Felici S; Ferrante M; Mannina D; Molinari AL; Musto P; Musuraca G; Merli M; Sartori R; Tani M; Varettoni M; Vitolo U; Orsucci L;

Impact of Immunochemotherapy with R-Bendamustine or R-CHOP in the Post-Induction Management of Treatment Naïve Advanced Stage Follicular Lymphoma Patients: A Subset Analysis of the FOLL12 Trial By the Fondazione Italiana Linfomi (FIL) in Blood

2021
AOU Città della Salute di Torino
ASL Biella

Luminari S; Nizzoli ME; Chiarenza A; Mannina D; Tucci A; Boccomini C; Farina L; Olivieri J; Marcheselli L; Ferrero S; Arcaini L; Pulsoni A; Musuraca G; Califano C; Merli M; Bari A; Conconi A; Re F; Balzarotti M; Ladetto M; Patti C; Pinto A; Cabras MG; Musto P; Gini G; Arcari A; Manni M; Versari A; Federico M; et alii...

RESPONSE ADAPTED POST INDUCTION THERAPY IN FOLLICULAR LYMPHOMA: UPDATED RESULTS OF THE FOLL12 TRIAL BY THE FONDAZIONE ITALIANA LINFOMI (FIL) in Haematologica

2021
ASL Biella

Luminari S; Galimberti S; Versari A; Tucci A; Boccomini C; Farina L; Zaja F; Marcheselli L; Ferrero S; Arcaini L; Pulsoni A; Musuraca G; Califano C; Merli M; Bari A; Conconi A; Del Giudice I; Re F; Stefani PM; Usai SV; Perrone T; Gini G; Falini B; Gattei V; Manni M; Ladetto M; Mannina D; Federico M;

NEXT GENERATION SEQUENCING PROVIDES NOVEL MOLECULAR MARKERS FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA: BIOLOGICAL RESULTS FROM FONDAZIONE ITALIANA LINFOMI (FIL) FOLL12 TRIAL in Haematologica

2021
ASL Biella

Genuardi E; Ferrero S; Della Starza I; Grassi S; Bomben R; Mantoan B; Drandi D; Dogliotti I; Alessandria B; Ferrante M; Ragaini S; Civita AM; Ghiggi C; Pulsoni A; Ronconi S; Merli M; Califano C; Castellino C; Bari A; Conconi A; De Novi LA; Del Giudice I; Gattei V; Galimberti S; Luminari S; Ladetto M; Federico M;

PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability. in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc / Mod Pathol. 2020 Jul;33(7):1398-1409. doi: 10.1038/s41379-020-0497-0. Epub 2020 Feb 17.

2020
ASL Biella
AOU Città della Salute di Torino

Vanoli A; Solcia E; Corazza GR; Paulli M; Pietrabissa A; Viglio A; Pedrazzoli P; Luinetti O; Ciccocioppo R; Barresi V; Silano M; Usai P; Sandri G; Quaquarini E; Papi C; Perfetti V; Orlandi A; Cantoro L; Giannone AG; Biletta E; Astegiano M; Reggiani Bonetti L; Oreggia B; Lenti MV; D'Odorico A; Zingone F; D'Incà R; Vecchi M; Caprioli F; et alii...

Correction: PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability. in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc / Mod Pathol. 2020 Jul;33(7):1453. doi: 10.1038/s41379-020-0512-5.

2020
ASL Biella
AOU Città della Salute di Torino

Di Sabatino A; Vanoli A; Solcia E; Corazza GR; Viglio A; Paulli M; Pietrabissa A; Pedrazzoli P; Luinetti O; Ciccocioppo R; Barresi V; Silano M; Usai P; Sandri G; Quaquarini E; Papi C; Perfetti V; Orlandi A; Cantoro L; Giannone AG; Biletta E; Astegiano M; Bonetti LR; Oreggia B; Lenti MV; D'Odorico A; Zingone F; D'Incà R; Vecchi M; et alii...

Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi. in Journal of geriatric oncology / J Geriatr Oncol. 2020 Jan;11(1):37-40. doi: 10.1016/j.jgo.2019.06.020. Epub 2019 Jul 8.

2020
ASL Biella
AOU Città della Salute di Torino
AOU Alessandria
AOU Novara

Luminari S; Zanni M; Mammi C; Conconi A; Matteucci P; Bari A; Scalone R; Ferrero S; Ferrari A; Molinari AL; Liberati AM; Tani M; Gini G; Merli M; Tucci A; Musuraca G; Cavallo F; Nassi L; Salvi F; Merli F;

Clinical and molecular results of the phase II BRB (bendamustine, rituximab and bortezomib) trial of the fondazione italiana linfomi (FIL) for relapsed/refractory waldenström macroglobulinemia patients in Blood

2018
ASL Biella
AOU Città della Salute di Torino

Benevolo G; Ferrero S; Andriani A; Castiglione A; Baraldi A; Boccomini C; Cabras MG; Califano C; Cavallo F; Conconi A; Curreli L; Drandi D; Gaidano G; Felici S; Ferrante M; Mannina D; Merli M; Molinari AL; Musto P; Musuraca G; Rossi FG; Sartori R; Tani M; Varettoni M; Vitolo U; Orsucci L;

Myelodysplastic syndromes with hypocellular marrow: Clinical characteristics and evaluation of outcome in HemaSphere

2018
ASL Biella
ASL Città di Torino
ASL Asti
ASL Torino 4
ASL Torino 5
AO Cuneo
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Alessandria
ASL Novara

Santini V; Gioia D; Masiera E; Poloni A; Ferrero D; Fragasso A; Finelli C; Salvi F; Gaidano G; Oliva EN; Catarini M; Cametti G; Bonferroni M; Danise P; Tassara R; Allione B; Cilloni D; Castelli A; Centurioni R; Ciravegna G; Visani G; Musto P; Balleari E; Biale L; Capelli D; Frairia C; Galimberti S; Giaccone L; Macchi S; et alii...